Alzheimer’s research seeing ‘exceptionally high levels’ of innovation
Nearly two-thirds of pipeline products have first-in-class potential
Read More
Author: Dominic Tyer
Video surveillance could support dementia patients
But consent would be key for the use of home camera-based systems
Read More
Bayer lymphoma candidate wins FDA priority review
Regulator backs copanlisib
Read More
NHS risks missed opportunity to put mental health at heart of services
Mental health not a high enough priority for NHS vanguards, says King’s Fund
Read More
Biogen pays $120 million for late-stage stroke treatment Cirara
Strikes licensing deal with Remedy Pharmaceuticals
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
